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0.50 mg/L, respectively. There were 327 sequence types. The four most common sequence
types in homosexuals were ST4378, ST359, ST4654, and ST547; the two most common sequence
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Changes in sequence types of Neisseria gonorrhoeae 709isolates. There were significant differences in the sequence types in patients with different
sexual orientations (p < 0.001).
Conclusion: Oral cefixime or ceftriaxone injections were used as first-line drugs for the treat-
ment of gonorrhea from 2006 to 2013 because gonorrhea isolates had low minimum inhibitory
concentrations for these two drugs. The abrupt emergence of ST4378 (closely related to the
notorious ST1407) since 2009 is a cause for alarm. Changes in sexual behavior, including an in-
crease in sexual activity without the use of condoms, may have contributed to the peak in
gonorrhea in 2010. Further molecular epidemiological investigations are required.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Gonorrhea is a sexually transmitted infection caused by
Neisseria gonorrhoea. Along with chlamydia, syphilis, and
trichomoniasis, gonorrhea is among the most common
sexually transmitted infections and is a significant public
health problem worldwide.1 Research in the late 1990s
indicated that gonorrhea and genital ulcer diseases can
increase the spread of sexually transmitted HIV.2,3 Recent
research has continued to focus on the role of gonorrhea in
the spread of HIV.4,5 In particular, a study in 2005 indicated
that the rate of HIV transmission in patients with gonorrhea
can be up to five times greater than in those without
gonorrhea.6
Gonorrhea can also increase the risk of developing other
acute infections and complications. An effective treatment
for gonorrhea is urgently needed, but treatment options
are diminishing because N. gonorrhoeae has developed
resistance to several commonly used antimicrobial drugs,
such as the sulfonamides, penicillin, tetracyclines, and
quinolones.4
The World Health Organization estimated in 1999 that
approximately 340 million new cases of chlamydia, gonor-
rhea, syphilis, and trichomoniasis occur every year and that
most new cases occur in developing countries, including
Southeast Asia, sub-Saharan Africa, Latin America, and the
Caribbean.7 The diagnosis and treatment of gonorrhea can
be problematic because N. gonorrhoeae is difficult to cul-
ture and has developed resistance to many oral antibiotics.
This has led to the inadequate control of gonorrhea in many
parts of the world.
Surveillance of antimicrobial resistance in N. gonor-
rhoeae can help to identify new resistant strains and
changes in the pattern of resistance, ultimately assisting in
disease control. Current treatment guidelines recommend
the use of single-dose injectable or oral third-generation
cephalosporin (ceftriaxone or cefixime). The emergence
and spread of cephalosporin-resistant and multidrug-
resistant N. gonorrhoeae strains is a worrying trend, indi-
cating the need for careful monitoring and investigation.
Thus clinical laboratories must remain alert for the early
detection of resistant strains so they can implement more
appropriate control strategies. The treatment strategy and
prevention of gonorrhea require regular review and revision.
The Gonococcal Resistance to Antimicrobials Surveillance
Program of the Health Protection Agency reported in 2010that 17.4% of N. gonorrhoeae isolates in the UK had cefixime
minimum inhibitory concentration (MIC) values of
0.125mg/L and that 6.3%of isolates had cefiximeMIC values
0.25 mg/L. Thus the Health Protection Agency announced
that cefixime was no longer a suitable first-line treatment for
gonorrhea as the percentage of N. gonorrhoeae isolates with
a cefixime MIC 0.25 mg/L has exceeded 5%.8
There were 2265 cases of gonorrhea in Taiwan in 2010
and the annual incidence was 9.79 per 100,000 population,
higher than in 2009 (9.26 per 100,000) and the highest re-
ported incidence since 2006.3 In addition, disk diffusion
tests indicated that 9% of gonococci were resistant to
cefixime in 2003, but that resistance to cefixime and cef-
podoxime (another third-generation cephalosporin) were
16.4% and 21.2%, respectively, during 2006e2007.8,9 In
2006, a new surveillance program, the Gonococci-National
Isolate Collection for Epidemiology (G-NICE), began the
collection of gonococcal isolates from hospitals and clinics
to monitor changes in drug resistance and the molecular
epidemiology of gonococci in Taiwan. The G-NICE pre-
sented data for 2009 and 2010 in the Taiwan Epidemiology
Bulletin of 2010 and 2011.10,11 However, there has been no
longitudinal study of gonococcal resistance following the
establishment of G-NICE in 2006.
The results presented here provide the most recent in-
formation on the emergence and transmission of drug-
resistant gonococci in high-risk sexual networks in Taiwan.Materials and methods
Collection of gonococcal isolates
We collected 1111 gonococcal isolates at our Kun-Ming
Branch of Taipei City Hospital, Taiwan from April 2006 to
August 2013. Our Kun-Ming Branch is a specialized clinic for
sexually transmitted diseases in Taipei City. Twelve isolates
had incomplete data and nine isolates could not be cultured
for definitive identification. Thus 1090 isolates were used
for analysis.
According to the Taiwan Centers for Disease Control
(CDC) annual report, there were about 1500 confirmed
cases of gonorrhea per year in Taiwan after 2003 and about
500 of these cases were from Taipei City (23% of all cases in
Taiwan). Our hospital in Taipei City collected about 80e200
isolates of gonorrhea each year from 2006 to 2012.
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Gonococcal isolates were inoculated on chocolate agar
and incubated at 37C for 16e18 hours. Fresh colonies
were added to MuellereHinton solutions and the turbidity
was adjusted to 0.5e0.6 McFarland standards with a
nephelometer (BD Diagnostic Systems, Franklin Lakes, NJ,
USA).
Tests for drug susceptibility
The antimicrobial susceptibilities to penicillin, ciprofloxa-
cin, cefixime, cefpodoxime, and ceftriaxone were analyzed
using the disk diffusion method. Isolates that exhibited
resistance to cefixime or ceftriaxone by this assay were
further evaluated by the Epsilometer test (E-test) for the
determination of MIC values. Drug susceptibility was
determined by the size of the inhibition zone using the
BIOMIC V3 assay (Giles Scientific, Santa Barbara, CA, USA).
The results were interpreted according to the Clinical and
Laboratory Standards Institute guidelines for N. gonor-
rhoeae.12 Isolates with MICs of 0.25 mg/L were considered
susceptible.
Extraction of gonococcus DNA
DNA was extracted with the MasterPure Yeast DNA Purifi-
cation Kit (Epicentre Biotechnologies, Madison, WI, USA).
Gonococcal isolates were cultured on chocolate agar at
37C for 16e18 hours. The bacteria were then inoculated
into 100 mL of phosphate-buffered saline and mixed with
250 mL of a cell lysis solution. After the addition of 150 mL of
a protein precipitation solution, the mixture was vortexed
for 10 s and centrifuged (12,000g  10 minutes). To facili-
tate DNA precipitation, 500 mL of 100% isopropanol was
added to the supernatant. The precipitated DNA was rinsed
with 70% alcohol and 100 mL of a hydration solution was
added to dissolve the extracted DNA. The concentration of
the extracted DNA was determined by spectrophotometry
at 260 nm. The DNA was stored at 20C prior to further
study.
Neisseria gonorrhoeae-multi Antigen Sequence
Typing
The Neisseria gonorrhoeae-multi Antigen Sequence Typing
(NG-MAST) molecular typing of gonococcal isolates was
conducted by sequencing the internal fragments of two
highly polymorphic loci, por and tbpB.13 The por gene
(750 bp) was amplified by the polymerase chain reaction
(PCR) using the forward primer 50-CAA GAA GAC GAC CTC
GGC AA-30 and the reverse primer 50-CCG ACA ACC ACT TGG
T-30. The tbpB gene (600 bp) was amplified by PCR using the
forward primer 50-CGTTGTCGGCAGCGCGAAAAC-30 and the
reverse primer 50-TTC ATC GGT GCG CTC GCC TTG-30. The
PCR conditions have been reported previously.14 The DNA
sequences of isolated gonococci were analyzed using Bio-
Numerics Version 5.0 (Applied Maths NV, Sint-Martens-
Latem, Belgium). The sequence data of each por and tbpB
genewere uploaded to the NG-MASTwebsite (www.ng-mast.
net) to obtain the allele number and the sequence type (ST).Statistical analysis
We use the Chi-square test to assess the relationships
between STs and the clinical characteristics of the infected
patients, including sexual orientation, HIV status, and
syphilis status; p Z 0.001 was considered statistically sig-
nificant (Table 1). SAS Version 9.03 (SAS Institute Inc., Cary,
North Carolina, USA) was used for the statistical analysis.Results
Drug resistance
In our study, the annual numbers of gonorrhea isolates from
2006 to 2013 were as follows: 74 (2006), 134 (2007), 107
(2008), 120 (2009), 167 (2010), 197 (2011), 179 (2012), and
112 (2013).
We initially tested the drug susceptibility of all 1090
bacterial isolates by the disc diffusion assay. The results
indicated that 61.01% of isolates were resistant to peni-
cillin, 83.39% were resistant to ciprofloxacin, 9.63% were
resistant to cefpodoxime, 6.70% were resistant to cefixime,
and 2.39% were resistant to ceftriaxone. The E-test results
for the resistant strains showed that the ceftriaxone MICs of
all the tested isolates were 0.50 mg/L (range
0.016e0.50 mg/L); the cefixime MICs were 0.125 mg/L in 14
isolates and 0.19 mg/L in three isolates; and the other 109
tested isolates had decreased susceptibility to ceftriaxone
(MIC 0.125 mg/L, range 0.125e0.50 mg/L). The MIC50
values of ceftriaxone and cefixime were 0.047 mg/L and
0.032 mg/L, respectively, and the MIC90 values of ceftri-
axone and cefixime were 0.25 mg/L and 0.094 mg/L,
respectively.
Fig. 1 shows the susceptibility of the isolates to the five
different antibiotics annual from 2006 to 2013. Ceftriaxone
susceptibility remained the highest and nearly 100% of
isolates were susceptible to this drug in most years,
although the susceptibility dropped in 2010 (91.02%) and
2013 (92.86%). The isolates had similar changes in suscep-
tibility to cefixime and cepodoxime over the study period,
with minima in 2007 (79.85% and 74.63%) and maxima in
2013 (100% for both). Penicillin and ciprofloxacin suscepti-
bilities were low throughout the study period. Penicillin
susceptibility was 0% in 2007, 2008, and 2009 and cipro-
floxacin susceptibility ranged from 20.36% (2010) to 2.68%
(2013). Previous studies of gonorrhea in Taiwan have re-
ported similar resistance patterns for these two
antibiotics.15,16
NG-MAST STs of isolates
Fig. 2 shows the antibiotic susceptibility of the 27 most
common STs during the study period. Among the 1090 iso-
lates, there were 327 STs. There was one isolate each for
212 STs, two isolates each for 35 STs, and three to 58 iso-
lates each for the other 80 STs. Twenty-seven STs (ST4378,
ST421, ST359, ST419, ST4654, ST547, ST225, ST7848,
ST2992, new, ST2253, ST1614, ST2178, ST2180, ST2175,
ST5809, ST835, ST2194, ST3680, ST5232, ST4919, ST2179,
ST3684, ST5877, ST4988, ST2422, and ST3081) accounted
Table 1 Demographic, behavioral, and clinical characteristics of study participants
Sex HIV Syphilis Sexual orientation
Male Female HIV() HIV(þ) Syphilis() Syphilis(þ) Homosexual Heterosexual Bisexual
n (%) 1028 (94.31) 62 (5.69) 721 (69.86) 311 (30.14) 803 (82.70) 168 (17.30) 481 (44.95) 512 (47.85) 77 (7.20)
Male 0e20 20e30 30e40 40e50 50e60 60e70 70e80 80e90
2006 72 2 22 25 13 7 1 1 1
2007 125 4 40 53 19 6 0 3 0
2008 100 4 43 36 11 3 3 0 0
2009 107 5 39 37 14 9 2 1 0
2010 153 4 63 55 20 7 4 0 0
2011 186 8 78 71 18 5 5 1 0
2012 175 3 72 79 15 4 0 2 0
2013 110 4 51 43 7 3 2 0 0
Total 1028 34 408 399 117 44 17 8 1
Female 0e20 20e30 30e40 40e50 50e60 60e70 70e80 80e90
2006 2 1 1 0 0 0 0 0 0
2007 9 2 5 2 0 0 0 0 0
2008 7 4 1 2 0 0 0 0 0
2009 13 0 11 1 1 0 0 0 0
2010 14 1 10 3 0 0 0 0 0
2011 11 3 7 1 0 0 0 0 0
2012 4 2 0 2 0 0 0 0 0
2013 2 0 2 0 0 0 0 0 0
Total 62 13 37 11 1 0 0 0 0
Changes in sequence types of Neisseria gonorrhoeae 711for >50% of the total. The six most common STs (ST4378,
ST421, ST359, ST419, ST4654, ST547) each had >25 iso-
lates. The most common sequence type in our study was
ST4378 and it accounted for 5.32% (58 isolates) of the total
(Fig. 2).
Of the STs shown in Fig. 2, 0e25% of the isolates were
susceptible to penicillin. For ciprofloxacin, the percentage
of susceptibility in most STs was 0e33%, but this was 89.8%
in ST359 and 62.07% in ST547. Most STs were susceptible to
cefixime and ceftriaxone, but four STs had low suscepti-
bility to cefixime (ST2253, 26.32%; ST2180, 37.50%; ST835,
42.86%; and ST3680, 64.29%) and two STs had low suscep-
tibility to ceftriaxone (ST2253, 73.68%; ST3680, 71.43%).
Notably, ST2253 and ST3680 had a high resistance to
cefixime and ceftriaxone. Most STs were susceptible to
cefpodoxime (range 78.57e100%), but three of 16 isolatesFigure 1. Antibiotic susceptibility of gonorrhea isolates from
2006 to 2013.of ST2180 (18.75%), three of 14 isolates of ST835 (21.43%),
and three of 19 isolates of ST2253 (15.79%) had low sus-
ceptibilities to cefpodoxime.
Antibiotic susceptibility patterns of drug-resistant
gonococci
Based on the results of the disc diffusion assays, we clas-
sified the 1090 isolates into six drug susceptibility pat-
terns,11 with Type 1 having the lowest susceptibility and
Type 6 having the highest susceptibility. The antibiotic
susceptibility patterns were further simplified into three
groups: those with low (Types 1 and 2), intermediate (Types
3 and 4), and high (Types 5 and 6) susceptibility.
Most isolates of the 21 most common STs had interme-
diate to low resistance to ceftriaxone, cefixime, and cef-
podoxime. Some isolates of ST4378, ST2253, ST2180, ST835,
ST419, and ST2194 showed high resistance (Fig. 3).
Isolates of most STs were susceptible to cefixime and
ceftriaxone, but only ST2253, ST2180, ST835, and ST3680
showed higher resistance to these two drugs (Figs. 2 and 3).
Finally, we examined the distribution of different STs in
homosexuals and heterosexuals (Fig. 4). The results indi-
cated that ST4378, ST359, ST4654, ST547, ST2992, ST2253,
ST1614, and ST5232 were mainly from male homosexual
patients, but ST421, ST419, ST225, ST2175, ST2194, and
ST2178 were mainly from heterosexual patients. There
were distinctly different susceptibility patterns in these
two groups. Heterosexual patients (with ST421, ST419,
ST225, ST2175, and ST2194) mostly had gonococci with
medium resistance (Types 3 or 4), but homosexual patients
Figure 2. Percentage of susceptible isolates among the 27 most common gonorrhea sequence types from 2006 to 2013.
712
C
.-W
.
C
h
e
n
g
e
t
a
l.
Figure 3. Antibiotic susceptibility of the 21 most common gonorrhea sequence types from 2006 to 2013. High resistance, Types 1
and 2; intermediate resistance, Types 3 and 4; and low resistance, Types 5 and 6.
Changes in sequence types of Neisseria gonorrhoeae 713had isolates with either low (Types 1 or 2) or very high (Type
6) susceptibility.
There were 58 isolates with ST4378. The ceftriaxone
MICs of these 58 isolates ranged from <0.016 mg/L to
0.19 mg/L; those <0.25 mg/L were considered susceptible.
The cefixime MICs of these isolates ranged from
<0.016 mg/L to 0.094 mg/L and <0.25 mg/L were consid-
ered susceptible.Discussion
The number of gonorrhea isolates in our study increased
from 2006 to 2012. The increasing rate (about 20% each
year) was higher than the mean rate (about 0.4% each
year17) of our population increase in the past 10 years in
Taiwan. This means that the increase in cases of gonorrhea
was not only due to a natural increase in the population.
The incidence rate of gonorrhea was much lower than those
of neighboring Asian countries (the annual incidence of
Neisseria gonorrhoeae in Southeast Asia in 2008 for menFigure 4. Distribution of the 21 most common gonorrhea sequenc
to 2013. ST4378, ST359, ST4654, and ST547 were common in hom
erosexual patients.was 37.0 per 1000 population and 16.2 per 1000 population
for women18). Therefore our incidence rate of gonorrhea
might be underestimated.
After the establishment of the Taiwan CDC on July 1,
1999, there were increasing numbers of reported sexually
transmitted diseases, including syphilis and gonorrhea. Prior
to the establishment of the Taiwan CDC, most patients with
sexually transmitted diseases sought help from local medical
doctors or bought medicine for themselves at pharmacies.
Taiwanese citizens have become more educated in recent
years and now visit large hospitals for the treatment of se-
vere diseases. These large hospitals are required by the
Communicable Disease Prevention Act 2007 to report to the
Taiwan CDC as soon as possible. Therefore we can now
identify more cases of the disease; in the past, no-one knew
about patients with sexually transmitted diseases.
However, the number of isolates in 2013 was much lower
than in other years as our data was only collected up to
August 2013. We did not have the complete data for the
whole of 2013. The results of the G-NICE program indicated
a similar trend to our study in that the number of gonorrheae types in patients with different sexual preferences from 2006
osexual patients and ST421 and ST419 were common in het-
Figure 5. (A) Changes in the four most common gonorrhea
sequence types among homosexual men from 2006 to 2013. (B)
Changes in the three most common gonorrhea sequence types
among heterosexuals from 2006 to 2013.
714 C.-W. Cheng et al.isolates in Taiwan increased by 19% from 2009 (519 isolates)
to 2010 (644 isolates). The proportion of isolates reported
to the CDC also increased from 24.3% (519 isolates, 2137
cases) in 2009 to 28.4% (644 isolates, 2265 cases) in 2010.10
This may indicate that there are an increased number of
cases of gonorrhea in Taiwan, more patients seeking med-
ical treatment, or more clinicians reporting cases to the
Taiwan CDC. The results of our disk diffusion tests showed
that a high proportion of N. gonorrhoeae isolates were
resistant to penicillin (97.07%) and ciprofloxacin (87.88%).
Susceptibility to ceftriaxone remained the highest and
nearly 100% of isolates were susceptible to this drug. Ac-
cording to the Clinical and Laboratory Standards Institute
standards, isolates with cefixime and ceftriaxone MICs of
0.25 mg/L are considered as susceptible. In the G-NICE
2010 program, only one isolate had a ceftriaxone MIC of
0.125 mg/L and no isolate had ceftriaxone MIC >0.25 mg/L;
there were 28 isolates (4.35%) with cefixime MICs of
0.125 mg/L and five isolates (0.78%) had MICs of
0.25 mg/L.
In our study, none of the N. gonorrhoeae isolates had
cefixime MICs of 0.25 mg/L and the maximum MICs of
cefixime and ceftriaxone remained the same in 2009 and
2010 (0.125 mg/L and 0.38 mg/L, respectively). Our results
also showed that the highest MICs of cefixime and ceftri-
axone were 0.19 mg/L and 0.50 mg/L, respectively. Nearly
all these isolates were susceptible based on the Clinical and
Laboratory Standards Institute standards (MIC 0.25 mg/L),
although the MIC90 values of cefixime and ceftriaxone
(0.25 mg/L and 0.094 mg/L, respectively) in our study were
both higher than that reported by the G-NICE study in 2009
(0.064 mg/L for both) and 2010 (cefixime, 0.19 mg/L; cef-
triaxone, 0.064 mg/L),9,10 Thus we still recommend oral
cefixime and injectable ceftriaxone as first-line drug
treatments for gonococcal infections in Taiwan. Our results
indicated that gonorrhea isolates had an increasing sus-
ceptibility to cefixime and cefpodoxime from 2007 to 2012,
possibly because of improving antibiotic stewardship and
control in Taiwan.13,19,20
Patients carrying the same ST may belong to the same
transmission network. Thus ST421 and ST419 remained the
most common STs in 2009 and 2010 (from G-NICE data);
these were the second and fourth most common STs in our
study, respectively, and were most common in heterosexual
patients. These STs peaked in 2010. ST4378 was the most
common ST in our study (58 isolates) and there was only one
isolate of ST1407. ST4378 is closely related to the globally
successful ST1407, which is notorious for its resistance to
cefixime and ceftriaxone. In fact, the porB sequence of
ST4378 and ST1407 differed by only one nucleotide.21 This
emerging ST might have been introduced to Taiwan via
homosexual patients and circulated in a high-risk sexual
network thereafter. This is an alarming result. We must
have more careful follow up to patients with gonorrhea
with ST4378 to ensure that they receive the correct anti-
biotic treatment and to prevent further spread of the
infection. Fortunately, all the isolates with ST4378 in our
study were sensitive to cefixime and ceftriaxone. Contin-
uous collaborative surveillance at the global level is very
important.
Our analysis of changes in STs over time indicated that
ST4378, ST359, and ST4654, which are most common inhomosexual patients, appeared after 2009. By contrast,
ST547 was also common in homosexual patients, but
decreased from 2006 to 2009 (Fig. 5A). This might be
because these different STs are from different homosexual
sources. Again, this trend should be followed in the coming
years and further molecular biological evaluation might be
helpful.
ST547 decreased from 2006 to 2009, but ST359 has
increased since 2009 (Fig. 5A). ST547 and ST359 were most
common in homosexual patients and had similar suscep-
tibility patterns (low resistance). The G-NICE data indi-
cated that ST547 was not among the 13 most common STs
in 2009. However, a study by Wong et al22 in 2006 indi-
cated that ST547 was the most common ST in Taiwan and
that ST359 was not among the eight most common STs.
Therefore it appears that ST359 might have replaced
ST547 in Taiwan (Fig. 5A). The low resistance of ST547
might be related to its decrease from 2006 to 2009. It
might imply that ST547 could be easily controlled by an-
tibiotics and not cause any further epidemics. The intro-
duction and upsurge of ST359 might be due to its link with
other countries, in particular the UK. Moreover, ST547,
ST359, and ST225 are three of the seven major genotypes
in men who have sex with men in the UK.23 In our study,
ST225 was very different and was most common in het-
erosexuals, increasing from 2006 to 2009, but disappear-
ing after 2012 (Fig. 5B). This trend should be followed in
the coming years; the clinical implications of this change
require further evaluation. In 2010 there was a maximum
number of patients with gonorrhea at our institution, both
homosexuals and heterosexuals. Changes in sexual
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Changes in sequence types of Neisseria gonorrhoeae 715behavior, including more sex parties without the use of
condoms may have contributed to this peak.
Previous studies have reported that ST359 and ST547
were two of the seven major genotypes in men who have
sex with men in the UK. These results should be considered
in the determination of the most appropriate antimicrobial
treatment for patients with gonorrhea. At present, we
suggest the treatment of gonorrhea with oral cefixime or
intramuscular ceftriaxone as a first-line treatment. For
homosexual patients with gonorrhea, drug resistance must
be considered and an adequate dose and frequency of
antimicrobial treatment should be given.
We further analyzed the 21 most prevalent STs in
patients of different sexual orientation, with or without
HIV, and with or without syphilis (Table 2). ST4378, ST359,
ST4654, and ST547 were the most common in homosexual
patients and ST421 and ST419 were the most common in
heterosexual patients (p < 0.001). However, the presence
of HIV and syphilis were unrelated to any STs, although our
sample sizes were too small for meaningful analysis. In
2009, Bernstein et al24 reported a similar result.
There were some limitations in our study. Our isolates
were only collected from symptomatic patients. Thus, we
cannot make any inferences about the epidemiology of non-
genital N. gonorrhoeae infections or asymptomatic uro-
genital infections. Although our sample size (1090 isolates)
was not very small, 212 of the 327 types of STs (64.8%)
contained only one isolate. Meaningful analysis of these 212
STs is difficult. Future analysis of more isolates would allow
a more complete evaluation of the relationship between
different STs and comorbid diseases.
Oral cefixime or ceftriaxone injections remained the
first-line drugs for the treatment of gonorrhea from 2006 to
2013 in Taiwan because gonorrhea isolates had low MICs for
these two drugs. The abrupt emergence of ST4378 (closely
related to the notorious ST1407) since 2009 is a cause for
alarm. Changes in sexual behavior without the use of
condoms may have contributed to the peak in cases of
gonorrhea in 2010. Further molecular epidemiological in-
vestigations are crucial.
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